BIO-key International (STU:BJO0) EBIT: €-5.62 Mil (TTM As of Mar. 2026)

What is BIO-key International EBIT?

BIO-key International STU:BJO0 31 EBIT is €-5.62 Mil as of Mar. 2026. GuruFocus rates STU:BJO0 with a GF Score™ of 31/100 and a GF Value™ of €253.44. The stock has 3 warning signs investors should review.

BIO-key International's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €-0.15 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €-5.62 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. BIO-key International's annualized ROC % for the quarter that ended in Mar. 2026 was -12.00%. BIO-key International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -684.44%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. BIO-key International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -184.86%.

BIO-key International (STU:BJO0) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

BIO-key International's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

	ROC % (Q: Mar. 2026 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2025 )	+	Invested Capital (Q: Mar. 2026 ))	/ count )
=	-0.548 * ( 1 - 0% )	/	( (4.619	+	4.516)	/ 2 )
=	-0.548	/	4.5675
=	-12.00 %

where

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	7.091	-	1.241	-	( 2.302	-	max(0, 2.644	-	3.875	+	2.302	))
=	4.619

	Invested Capital		(Q: Mar. 2026 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	7.056	-	1.419	-	( 1.945	-	max(0, 2.759	-	3.88	+	1.945	))
=	4.516

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

BIO-key International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2026 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2025		Q: Mar. 2026
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.616	/	( ( (0.099 + max(-0.489, 0))	+	(0.081 + max(-0.224, 0)) )	/	2 )
=	-0.616	/	( ( 0.099	+	0.081 )	/	2 )
=	-0.616	/	0.09
=	-684.44 %

where Working Capital is:

	Working Capital		(Q: Dec. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.043	+	0.317	+	0.213)	-	(1.241	+	0.489	+	0.332)
=	-0.489

	Working Capital		(Q: Mar. 2026 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.361	+	0.292	+	0.282)	-	(1.419	+	0.74	+	-4.4408920985006E-16)
=	-0.224

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

BIO-key International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2026 )
	=	-5.616	/	3.038
	=	-184.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BIO-key International EBIT Related Terms

BIO-key International EBIT Historical Data

* Premium members only.

The historical data trend for BIO-key International's EBIT can be seen below:

BIO-key International EBIT Chart

BIO-key International Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EBIT

Get a 7-Day Free Trial

-4.47

-11.25

-7.74

-3.96

-6.05

BIO-key International Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EBIT	Get a 7-Day Free Trial															-0.65	-0.99	-0.81	-3.66	-0.15

STU:BJO0 vs IVDA, AGSS, IWAL: EBIT Comparison

For the Security & Protection Services subindustry, BIO-key International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BIO-key International EV-to-EBIT vs Business Services Industry

For the Business Services industry and Industrials sector, BIO-key International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BIO-key International's EV-to-EBIT falls into.

Save Embed

31GF Score

BIO-key International Inc STU:BJO0

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BIO-key International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-5.62 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of €-5.62 Mil mean?

BIO-key International (STU:BJO0) has a EBIT of €-5.62 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on BIO-key International.

Is BIO-key International's EBIT too high?

BIO-key International's current EBIT is €-5.62 Mil. Overall, BIO-key International has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.

How does BIO-key International's EBIT compare to IVDA and AGSS?

BIO-key International's EBIT of €-5.62 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Business Services company?

A good EBIT depends on the Business Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on BIO-key International. BIO-key International's current EBIT is €-5.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BIO-key International stock overvalued right now?

BIO-key International (STU:BJO0) has a current EBIT of €-5.62 Mil. The stock's GF Value™ is €253.44, compared to a current price of €460.80 — trading 81.8% above its estimated fair value. The current EBIT is €-5.62 Mil. BIO-key International's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For BIO-key International (STU:BJO0), the current EBIT is €-5.62 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BIO-key International (STU:BJO0) Overvalued in 2026?

Based on GuruFocus' analysis, BIO-key International stock appears to be overvalued. The current stock price of €460.80 is trading 81.8% above its estimated GF Value™ of €253.44.

Key valuation signals for STU:BJO0:

EBIT: €-5.62 Mil
GF Value™: €253.44 vs. price of €460.80 (81.8% above fair value)
GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the STU:BJO0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BIO-key International Business Description

Industry Industrials Business Services

Comparable Companies IVDA AGSS IWAL SUGP VRME DTII GFAI OSTO:ASSA B TSE:9735 ALLE OSTO:SECU B XTAE:NXSN SZSE:002236 MSA ADT BCO BRC TSE:2331 OSTO:LOOMIS GEO

Other Exchanges BKYI:USA

Address 101 Crawfords Corner Road, Suite 4116, Holmdel, NJ, USA, 07753

Website https://www.bio-key.com

BIO-key International Inc is a identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and high-quality, low-cost accessory fingerprint scanner and FIDO-compliant hardware to provide a full and complete solution for identity-innovating customers. The company operates as one operating segment. Its solutions are Passwordless Authentication, Secure Roving Employees, Education, Financial Services, Government, Healthcare, Manufacturing, etc.

31GF Score

Get the complete analysis for STU:BJO0

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€460.80

Price

€253.44

GF Value

View STU:BJO0 Analysis

See EBIT data for all stocks →